Zobrazeno 1 - 10
of 2 754
pro vyhledávání: '"Pierre I., Karakiewicz"'
Autor:
Fabian Falkenbach, Giovanni Mazzucato, Zhe Tian, Pierre I. Karakiewicz, Markus Graefen, Thomas Steuber, Derya Tilki, Daniel Koehler, Burkhard Beyer, Pierre Tennstedt, Sophie Knipper, Lars Budäus, Tobias Maurer
Publikováno v:
European Urology Open Science, Vol 70, Iss , Pp 1-7 (2024)
Background and objective: In patients with oligorecurrent prostate cancer (PCa), prostate-specific membrane antigen–targeted radioguided surgery (PSMA-RGS) prolongs treatment-free survival. Data on patient-reported outcome measures (PROMs) are lack
Externí odkaz:
https://doaj.org/article/eae709c66f0d464ab1a9165bf132e840
Autor:
Pietro Scilipoti, Giuseppe Rosiello, Federico Belladelli, Marco Gambirasio, Francesco Trevisani, Arianna Bettiga, Chiara Re, Giacomo Musso, Francesco Cei, Lucia Salerno, Zhe Tian, Pierre I. Karakiewicz, Alexandre Mottrie, Isaline Rowe, Alberto Briganti, Roberto Bertini, Andrea Salonia, Francesco Montorsi, Alessandro Larcher, Umberto Capitanio
Publikováno v:
European Urology Open Science, Vol 69, Iss , Pp 73-79 (2024)
Background and objective: Metabolic syndrome (MetS) is a clinical condition associated with higher rates of overall and cardiovascular mortality. There is scarce evidence regarding the impact of MetS on surgical and functional outcomes for patients u
Externí odkaz:
https://doaj.org/article/87c3526ed5904a1b9f4186f24703b70c
Autor:
Francesco Chierigo, Rocco Simone Flammia, Gabriele Sorce, Benedikt Hoeh, Lukas Hohenhorst, Andrea Panunzio, Zhe Tian, Fred Saad, Marcus Graefen, Michele Gallucci, Alberto Briganti, Francesco Montorsi, Felix K.H. Chun, Shahrokh F. Shariat, Alessandro Antonelli, Giovanni Guano, Guglielmo Mantica, Marco Borghesi, Nazareno Suardi, Carlo Terrone, Pierre I. Karakiewicz
Publikováno v:
Current Urology, Vol 18, Iss 2, Pp 128-132 (2024)
Abstract. Objectives. This study aimed to test the association between of type and number of D'Amico high-risk criteria (DHRCs) with cancer-specific mortality (CSM) in high-risk prostate cancer patients treated with radical prostatectomy. Materials a
Externí odkaz:
https://doaj.org/article/63acf018d2eb4171ba4db35d7818dd58
Autor:
Emanuele Zaffuto, Shahrokh F. Shariat, Agostino Mattei, Marco Moschini, Pierre I. Karakiewicz
Publikováno v:
European urology. 75(4)
Autor:
Okyaz Eminaga, Fred Saad, Zhe Tian, Ulrich Wolffgang, Pierre I. Karakiewicz, Véronique Ouellet, Feryel Azzi, Tilmann Spieker, Burkhard M. Helmke, Markus Graefen, Xiaoyi Jiang, Lei Xing, Jorn H. Witt, Dominique Trudel, Sami-Ramzi Leyh-Bannurah
Publikováno v:
npj Imaging, Vol 2, Iss 1, Pp 1-12 (2024)
Abstract Malignancy grading of prostate cancer (PCa) is fundamental for risk stratification, patient counseling, and treatment decision-making. Deep learning has shown potential to improve the expert consensus for tumor grading, which relies on the G
Externí odkaz:
https://doaj.org/article/c4b8543e519440bb95cf3c3b228ab60d
Autor:
Marco Moschini, Emanuele Zaffuto, Shahrokh F. Shariat, Agostino Mattei, Pierre I. Karakiewicz
Publikováno v:
European Urology. 75:e95
Autor:
Moschini M; Department of Urology, Vienna General Hospital, Medical University of Vienna, Vienna, Austria; Department of Urology, Urological Research Institute, Vita-Salute University, San Raffaele Scientific Institute, Milan, Italy; Klinik für Urologie, Luzerner Kantonsspital, Lucerne, Switzerland. Electronic address: marco.moschini87@gmail.com., Zaffuto E; Department of Urology, Urological Research Institute, Vita-Salute University, San Raffaele Scientific Institute, Milan, Italy; Department of Urology, University of Montreal, Montreal, Canada., Mattei A; Klinik für Urologie, Luzerner Kantonsspital, Lucerne, Switzerland., Karakiewicz PI; Department of Urology, University of Montreal, Montreal, Canada., Shariat SF; Department of Urology, Vienna General Hospital, Medical University of Vienna, Vienna, Austria; Department of Urology, University of Texas Southwestern Medical Center, Dallas, TX, USA; Department of Urology, Weill Cornell Medical College, New York, NY, USA; Karl Landsteiner Institute of Urology and Andrology, Vienna, Austria.
Publikováno v:
European urology [Eur Urol] 2019 Apr; Vol. 75 (4), pp. e95. Date of Electronic Publication: 2018 Nov 30.
Autor:
Fiorentino A; Radiation Oncology Department, F. Miulli General Regional Hospital, Acquaviva delle Fonti, Italy. Electronic address: albafiorentino@hotmail.it., Errico A; Radiation Oncology Department, R. Dimiccoli Hospital, Barletta, Italy., Scarcia M; Urology Department, F. Miulli General Regional Hospital, Acquaviva delle Fonti, Italy.
Publikováno v:
European urology [Eur Urol] 2019 Apr; Vol. 75 (4), pp. e93-e94. Date of Electronic Publication: 2018 Nov 27.
Autor:
Zaorsky NG; Department of Radiation Oncology, Penn State Cancer Institute, Hershey, PA, USA; Department of Public Health Sciences, Penn State College of Medicine, Hershey, PA, USA. Electronic address: nicholaszaorsky@gmail.com., Spratt DE; Department of Radiation Oncology, University of Michigan, Ann Arbon, MI, USA., Blanchard P; Department of Radiation Oncology, Gustave Roussy, Paris Sud University, Villejuif, France.
Publikováno v:
European urology [Eur Urol] 2019 Apr; Vol. 75 (4), pp. e96-e97. Date of Electronic Publication: 2018 Nov 22.
Autor:
Moschini M; Department of Urology, Vienna General Hospital, Medical University of Vienna, Vienna, Austria; Department of Urology, Urological Research Institute, Vita-Salute University, San Raffaele Scientific Institute, Milan, Italy; Klinik für Urologie, Luzerner Kantonsspital, Lucerne, Switzerland. Electronic address: marco.moschini87@gmail.com., Zaffuto E; Department of Urology, Urological Research Institute, Vita-Salute University, San Raffaele Scientific Institute, Milan, Italy; Department of Urology, University of Montreal, Montreal, Canada., Mattei A; Klinik für Urologie, Luzerner Kantonsspital, Lucerne, Switzerland., Karakiewicz PI; Department of Urology, University of Montreal, Montreal, Canada., Shariat SF; Department of Urology, Vienna General Hospital, Medical University of Vienna, Vienna, Austria; Department of Urology, University of Texas Southwestern Medical Center, Dallas, TX, USA; Department of Urology, Weill Cornell Medical College, New York, NY, USA; Karl Landsteiner Institute of Urology and Andrology, Vienna, Austria.
Publikováno v:
European urology [Eur Urol] 2019 Apr; Vol. 75 (4), pp. e98-e99. Date of Electronic Publication: 2018 Nov 30.